Core Viewpoint - As of December 4, a total of 128 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the longest consecutive net buying days is Aucma, which has seen net buying for 18 consecutive trading days [1] - Other notable stocks with significant net buying days include Source Pet, Hangxiao Steel Structure, Juhe Shun, Longxing Technology, Yuanda Environmental Protection, Beiba Media, Samsung Medical, and Hefeng Co., Ltd. [1]

工商登记变更后，相关登记信息如下： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 因业务发展需要，宁波三星医疗电气股份有限公司（以下简称"公司"）全资子公司宁波三星智能电气有 限公司于近日进行了经营范围变更，相关工商变更登记手续已办理完毕，并取得了宁波市市场监督管理 局换发的《营业执照》。 注册资本：64,165.28万人民币 成立日期：2010年03月01日 经营范围：一般项目：仪器仪表制造；仪器仪表销售；仪器仪表修理；电工仪器仪表制造；电工仪器仪 表销售；供应用仪器仪表制造；供应用仪器仪表销售；充电桩销售；集中式快速充电站；新能源汽车电 附件销售；电动汽车充电基础设施运营；新能源汽车换电设施销售；通信设备制造；智能仪器仪表制 造；智能仪器仪表销售；电容器及其配套设备制造；电容器及其配套设备销售；智能家庭消费设备制 造；智能家庭消费设备销售；物联网设备制造；变压器、整流器和电感器制造；智能输配电及控制设备 销售；输配电及控制设备制造；配电开关控制设备销售；配电开关控制设备研发；输变配电监测控制设 备销售；电力电子元器件销售 ...

证券日报网讯 12月4日晚间，三星医疗发布公告称，因业务发展需要，全资子公司宁波三星智能电气有 限公司于近日进行了经营范围变更，相关工商变更登记手续已办理完毕，并取得了宁波市市场监督管理 局换发的《营业执照》。 （文章来源：证券日报） ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-093 宁波三星医疗电气股份有限公司 关于全资子公司完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 因业务发展需要，宁波三星医疗电气股份有限公司（以下简称"公司"）全 资子公司宁波三星智能电气有限公司于近日进行了经营范围变更，相关工商变更 登记手续已办理完毕，并取得了宁波市市场监督管理局换发的《营业执照》。 工商登记变更后，相关登记信息如下： 法定代表人：程志浩 注册资本：64,165.28 万人民币 成立日期：2010 年 03 月 01 日 经营范围：一般项目：仪器仪表制造；仪器仪表销售；仪器仪表修理；电工 仪器仪表制造；电工仪器仪表销售；供应用仪器仪表制造；供应用仪器仪表销售； 充电桩销售；集中式快速充电站；新能源汽车电附件销售；电动汽车充电基础设 施运营；新能源汽车换电设施销售；通信设备制造；智能仪器仪表制造；智能仪 器仪表销售；电容器及其配套设备制造；电容器及其配套设备销售；智能家庭消 费设备制造；智能家庭消费设备销售；物联网 ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

资金面上看，今日高压氧舱概念板块获主力资金净流出0.45亿元，其中，4股获主力资金净流入，净流 入资金居首的是三星医疗，今日主力资金净流入497.59万元，净流入资金居前的还有澳洋健康、盈康生 命、威奥股份等，主力资金分别净流入132.39万元、89.09万元、69.15万元。 资金流入比率方面，盈康生命、威奥股份、澳洋健康等流入比率居前，主力资金净流入率分别为 2.53%、1.60%、1.49%。（数据宝） 截至12月3日收盘，高压氧舱概念上涨0.92%，位居概念板块涨幅第2，板块内，8股上涨，杭氧股份、 大湖股份、金陵药业等涨幅居前，分别上涨5.56%、1.13%、1.09%。跌幅居前的有倍益康、铁建重工、 盈康生命等，分别下跌0.40%、0.20%、0.20%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 培育钻石 | 2.72 | 快手概念 | -3.56 | | 高压氧舱 | 0.92 | MLOps概念 | -3.32 | | 中韩自贸区 | 0.77 | DRG/DIP | -3.21 | ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-092 宁波三星医疗电气股份有限公司 关于经营合同预中标的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）下属全资子公司宁波奥克斯 智能科技股份有限公司（以下简称"奥克斯智能科技"）于近日在国家电网有限公司 2025 年华中、川渝区域第二次联合采购 10kV 柱上变压器台成套设备协议库存招标采 购，国家电网有限公司 2025 年华中、川渝区域第二次联合采购 10kV 变压器协议库存 招标采购项目中被推荐为中标候选人，预计合计中标总金额约为 15,179.71 万元，现 将预中标情况公告如下： 一、国家电网项目预中标的主要内容 1、国家电网有限公司2025年华中、川渝区域第二次联合采购10kV柱上变压器台 成套设备协议库存招标采购项目 国家电网有限公司于近日在其电子商务平台（http://ecp.sgcc.com.cn）公告"国家 电网有限公司2025年华中、川渝区域第二次联合采购10kV柱上变压器台成套设备 ...

智通财经APP讯，三星医疗(601567.SH)发布公告，公司下属全资子公司宁波奥克斯智能科技股份有限 公司(简称"奥克斯智能科技")于近日在国家电网有限公司2025年华中、川渝区域第二次联合采购10kV柱 上变压器台成套设备协议库存招标采购，国家电网有限公司2025年华中、川渝区域第二次联合采购 10kV变压器协议库存招标采购项目中被推荐为中标候选人，预计合计中标总金额约为1.52亿元。 ...

三星医疗（601567）(601567.SH)发布公告，公司下属全资子公司宁波奥克斯智能科技股份有限公司(简 称"奥克斯智能科技")于近日在国家电网有限公司2025年华中、川渝区域第二次联合采购10kV柱上变压 器台成套设备协议库存招标采购，国家电网有限公司2025年华中、川渝区域第二次联合采购10kV变压 器协议库存招标采购项目中被推荐为中标候选人，预计合计中标总金额约为1.52亿元。 ...

三星医疗12月3日公告，下属全资子公司宁波奥克斯智能科技股份有限公司在国家电网有限公司2025年 华中、川渝区域第二次联合采购10kV柱上变压器台成套设备协议库存招标采购、10kV变压器协议库存 招标采购项目中被推荐为中标候选人，预计合计中标总金额约为1.52亿元。 ...